Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced the launch in Japan of its percutaneous analgesic and anti-inflammatory drug Loxonin® Gel 1% (generic name, loxoprofen sodium hydrate; approval for manufacture and marketing, June 9, 2010; drug price listing, September 24...
High-risk patients undergoing a coronary procedure such as placement of a stent who electively received an intra-aortic balloon pump (a device that can help improve blood flow) prior to the procedure did not experience a significantly lower overall rate of events such as heart attack...